Idarucizumab
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Idarucizumab and local guidelines before prescribing.
Specific reversal agent
Mechanism
Monoclonal antibody fragment binding dabigatran.
Uses
Reversal of dabigatran in life-threatening bleeding or urgent surgery.
Dosing
- Dabigatran: Idarucizumab 5 g IV. Dabigatran can also be removed by dialysis.
Gastroenterology: Gastroenterology Emergencies (Complete) - Idarucizumab | 5 g IV for dabigatran reversal.
Gastroenterology: Gastroenterology Emergencies (Complete) - Dabigatran: Idarucizumab 5 g IV. Haemodialysis is an option.
Haematology: Emergencies - Idarucizumab 5 g IV | Dabigatran reversal.
Haematology: Emergencies
Side effects
Headache, hypokalaemia, thrombosis risk after reversal.
Interactions
Specific to dabigatran.
Contraindications and cautions
None specific
Monitoring
Coagulation, bleeding
Pregnancy and breastfeeding
Use if life-threatening
Renal and hepatic impairment
No adjustment
Overdose and reversal
Not applicable
Special advice
Restart anticoagulation as soon as possible once bleeding controlled.
More from the textbook: uses, cautions and other points
- Dabigatran (thrombin inhibitor) | Mostly cleared by the kidneys - avoid if CrCl under 30. Dyspepsia. Reversal agent: idarucizumab
Haematology: Haemostasis and Thrombosis - Reversal - idarucizumab (dabigatran); andexanet alfa or prothrombin complex concentrate (Xa inhibitors) - per local policy.
Cardiology: Anatomy Physiology and Pharmacology - Reverse anticoagulants: vitamin K with PCC for warfarin; andexanet for apixaban or rivaroxaban GI bleeds; idarucizumab for dabigatran.
Gastroenterology: Gastroenterology Emergencies (Complete) - Blood pressure - long-term target systolic under about 130 mmHg after stroke (if tolerated); in acute intracerebral haemorrhage , lower systolic BP to about 130–140 mmHg within 6 hours (if over 150) and reverse anticoagulation urgently - prothrombin complex concentrate plus IV vitamin K (warfarin), idarucizumab (dabigatran), andexanet …
Neurology: Anatomy, Physiology and Pharmacology - Dabigatran: Idarucizumab.
Neurology: Stroke Emergencies - Dabigatran - idarucizumab (specific antibody); dabigatran is also removed by dialysis.
Haematology: Anatomy Physiology and Pharmacology - Idarucizumab (dabigatran) and andexanet alfa (factor Xa inhibitors) - specific DOAC reversal agents.
Haematology: Anatomy Physiology and Pharmacology - Dabigatran | Thrombin inhibitor; renal; dyspepsia; reverse with idarucizumab.
Haematology: Anatomy Physiology and Pharmacology
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (3 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Stroke Emergencies (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (4 mentions)
- Haematology: Emergencies (3 mentions)
- Haematology: Haemostasis and Thrombosis (4 mentions)
- Surgery: Major trauma and burns (1 mention)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (4 mentions)
- Clinical pharmacology and prescribing: Poisoning and overdose (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Acute Medicine: The acute medical take (1 mention)
- Clinical imaging: Neuroimaging — head, brain and spine (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- OSCEs II: Practical procedures, prescribing and acute care stations (1 mention)